Latest Solvay News & Updates

See the latest news and media coverage for Solvay. We track all announcements, press releases, and industry mentions in real time, all in one place.

Solvay

Global essential chemicals manufacturer

solvay.com

Headquarters: Brussels, Belgium
Company type: Public company
Number of employees: 10,000–17,000
Industry: Diversified Chemicals

Last updated October 19

Latest news about Solvay

In short: Solvay cut its 2026 outlook after Middle East conflict hurt results while advancing rare earth investments.

Company announcements

October 19 Solvay

Solvay reports Q3 2026 results and updates guidance

The company cites Middle East conflict impacts on its Sadara plant, lowering full-year EBITDA and cash flow forecasts while maintaining transformation commitments.

July 29 Solvay

Solvay reports record sales and strategic rare earth investment

The company achieved €259 million in structural savings and will expand heavy rare earth capabilities by 2026.

July 29 Solvay

Solvay reports Q2 2026 financial results and confirms full year guidance

Net sales dropped 7.4% organically due to soda ash pricing and Middle East conflicts. EBITDA fell 19.5%, while strategic rare earth investments were approved.

May 7 Solvay

Solvay reports Q1 results showing disciplined execution

Teams maintained stable fixed costs, achieved recurring savings, and demonstrated portfolio resilience amid volatility. Long-term choices enhance energy efficiency and supply security.

Media coverage

October 19 Reuters

Solvay cuts 2026 forecast after Middle East conflict hits Q3

Solvay cut its 2026 forecast after ‌the Middle East conflict and a peroxide plant shutdown at ⁠Sa...

October 15 Ad Hoc News

Solvay cuts 2026 outlook. JP Morgan target for Solvay stock is EUR 28.50

JP Morgan kept an overweight recommendation while cutting its target from EUR 30.00 to EUR 28.50, a EUR 1.50 reduction dated October 20, 2026. The...

October 4 Pharmaceutical Technology

Abbott to Acquire Solvay Pharmaceuticals for $6.6 Billion | Pharmaceutical Technology

Abbott Laboratories (Abbott Park, IL) agreed to acquire the pharmaceutical business of the Solvay Group (Brussels, Belgium) for EUR 4.5 billion ($6.6 billion) in cash...

July 31 Finanzen.ch

Solvay presented quarterly results

Solvay disclosed the business results for the quarter ended June 30, 2026 on July 29, 2026. Earnings per share amounted to EUR 0.36...

Never miss news about Solvay

Track Solvay and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Solvay competitors & trending companies

Browse news for competitors to Solvay and other trending companies.